Israel Vicente Toledo-Coronado

Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19

A. Ruiz-Margáin, M. S. González-Huezo, B. M. Román-Calleja, 2022, World journal of gastroenterology.

Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19

C. Aguilar-Salinas, A. Ruiz-Margáin, F. Cubero, 2021, Digestive and Liver Disease.